Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Slingluff, CL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 39 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Yamshchikov, G; Thompson, L; Ross, WG; Galavotti, H; Aquila, W; Deacon, D; Caldwell, J; Patterson, JW; Hunt, DF; Slingluff, CL
      Analysis of a natural immune response against tumor antigens in a melanomasurvivor: Lessons applicable to clinical trial evaluations

      CLINICAL CANCER RESEARCH
    2. Slingluff, CL; Yamshchikov, G; Neese, P; Galavotti, H; Eastham, S; Engelhard, VH; Kittlesen, D; Deacon, D; Hibbitts, S; Grosh, WW; Petroni, G; Cohen, R; Wiernasz, C; Patterson, JW; Conway, BP; Ross, WG
      Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: Immunologic and clinical outcomes

      CLINICAL CANCER RESEARCH
    3. Brinckerhoff, LH; Thompson, LW; Slingluff, CL
      Melanoma vaccines (vol 12, pg 163, 2000)

      CURRENT OPINION IN ONCOLOGY
    4. Harlow, SP; Krag, DN; Ashikaga, T; Weaver, DL; Meijer, SJ; Loggie, BW; Tanabe, KK; Whitworth, P; Kuhn, J; Kusminsky, R; Carp, NZ; Gadd, M; Rawlings, M; Slingluff, CL
      Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study

      MELANOMA RESEARCH
    5. Kilbridge, KL; Weeks, JC; Sober, AJ; Haluska, FG; Slingluff, CL; Atkins, MB; Sock, DE; Kirkwood, JM; Nease, RF
      Patient preferences for adjuvant interferon alfa-2b treatment

      JOURNAL OF CLINICAL ONCOLOGY
    6. Slingluff, CL; Colella, TA; Thompson, L; Graham, DD; Skipper, JCA; Caldwell, J; Brinckerhoff, L; Kittlesen, DJ; Deacon, DH; Oei, C; Harthun, NL; Huczko, EL; Hunt, DF; Darrow, TL; Engelhard, VH
      Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    7. Slingluff, CL
      'Mastectomy'

      VIRGINIA QUARTERLY REVIEW
    8. Zarour, HM; Kirkwood, JM; Kierstead, LS; Herr, W; Brusic, V; Slingluff, CL; Sidney, J; Sette, A; Storkus, WJ
      Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitoperecognized by melanoma-reactive CD4(+) T cells

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    9. Yang, SX; Kittlesen, D; Slingluff, CL; Vervaert, CE; Seigler, HF; Darrow, TL
      Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and-A3

      JOURNAL OF IMMUNOLOGY
    10. English, JC; Middleton, C; Patterson, JW; Slingluff, CL
      Cancer of the male breast

      INTERNATIONAL JOURNAL OF DERMATOLOGY
    11. Lippolis, JD; Denis-Mize, KS; Brinckerhoff, LH; Slingluff, CL; Galloway, DR; Engelhard, VH
      Pseudomonas exotoxin-mediated delivery of exogenous antigens to MHC class I and class II processing pathways

      CELLULAR IMMUNOLOGY
    12. Moore, MM; Borossa, G; Imbrie, JZ; Fechner, RE; Harvey, JA; Slingluff, CL; Adams, RB; Hanks, JB
      Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy

      ANNALS OF SURGERY
    13. Slingluff, CL
      Immunology of cancer

      SURGERY: BASIC SCIENCE AND CLINICAL EVIDENCE
    14. Slingluff, CL
      Targeting unique tumor antigens and modulating the cytokine environment may improve immunotherapy for tumors with immune escape mechanisms

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    15. Kittlesen, DJ; Thompson, LW; Gulden, PH; Skipper, JCA; Colella, TA; Shabanowitz, J; Hunt, DF; Engelhard, VH; Slingluff, CL
      Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: Implications for tumor vaccine development (vol 160, pg 2099, 1998)

      JOURNAL OF IMMUNOLOGY
    16. Brinckerhoff, LH; Kalashnikov, VV; Thompson, LW; Yamshchikov, GV; Pierce, RA; Galavotti, HS; Engelhard, VH; Slingluff, CL
      Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: Implications for peptide vaccines

      INTERNATIONAL JOURNAL OF CANCER
    17. Skipper, JCA; Gulden, PH; Hendrickson, RC; Harthun, N; Caldwell, JA; Shabanowitz, J; Engelhard, VH; Hunt, DF; Slingluff, CL
      Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifiesdominant naturally processed forms of CTL epitopes from MART-1 and gp100

      INTERNATIONAL JOURNAL OF CANCER
    18. HARTHUN NL; WEAVER AM; BRINCKERHOFF LH; DEACON DH; GONIAS SL; SLINGLUFF CL
      ACTIVATED ALPHA(2)-MACROGLOBULIN REVERSES THE IMMUNOSUPPRESSIVE ACTIVITY IN HUMAN BREAST-CANCER CELL-CONDITIONED MEDIUM BY SELECTIVELY NEUTRALIZING TRANSFORMING-GROWTH-FACTOR-BETA IN THE PRESENCE OF INTERLEUKIN-2

      Journal of immunotherapy
    19. WANG TS; LOWE L; SMITH JW; FRANCIS IR; SONDAK VK; DWORZANIAN L; FINKELSTEIN S; SLINGLUFF CL; JOHNSON TM
      COMPLETE SPONTANEOUS REGRESSION OF PULMONARY METASTATIC MELANOMA

      Dermatologic surgery
    20. COLELLA TA; KITTLESEN DJ; LUCKEY CJ; THOMPSON LW; SLINGLUFF CL; ENGELHARD VH
      THE PRESENTATION OF PEPTIDE ANTIGENS DERIVED FROM MELANOCYTE-DIFFERENTIATION PROTEINS BY CULTURED MELANOCYTES - IMPLICATIONS FOR TUMOR-IMMUNOTHERAPY

      The FASEB journal
    21. SETTLAGE RE; HENDRICKSON RC; DEACON D; CALDWELL JA; HUNT DF; SLINGLUFF CL
      A PEPTIDE FROM P68 IS AN EPITOPE FOR MELANOMA REACTIVE CYTOTOXIC T-LYMPHOCYTES

      The FASEB journal
    22. BRINCKERHOFF LH; GULDEN PH; HUNT DF; SLINGLUFF CL
      AT LEAST 3 HLA-A-ASTERISK-0201 ASSOCIATED MELANOMA PEPTIDE EPITOPES ARE SHED FROM GP100 POSITIVE CULTURED MELANOMA CELL-LINES

      The FASEB journal
    23. BRINCKERHOFF LH; DEACON D; KITTLESEN DJ; SLINGLUFF CL
      CRYOPRESERVATION OF HUMAN MONOCYTE-DERIVED CELLS FOR USE IN MELANOMA VACCINES

      Journal of leukocyte biology
    24. KITTLESEN DJ; THOMPSON LW; GULDEN PH; SKIPPER JCA; COLELLA TA; SHABANOWITZ JA; HUNT DF; ENGELHARD VH; SLINGLUFF CL
      HUMAN-MELANOMA PATIENTS RECOGNIZE AN HLA-A1-RESTRICTED CTL EPITOPE FROM TYROSINASE CONTAINING 2 CYSTEINE RESIDUES - IMPLICATIONS FOR TUMOR VACCINE DEVELOPMENT

      The Journal of immunology
    25. TUTING T; WILSON CC; MARTIN DM; KASAMON YL; ROWLES J; MA DI; SLINGLUFF CL; WAGNER SN; VANDERBRUGGEN P; BAAR J; LOTZE MT; STORKUS WJ
      AUTOLOGOUS HUMAN MONOCYTE-DERIVED DENDRITIC CELLS GENETICALLY-MODIFIED TO EXPRESS MELANOMA ANTIGENS ELICIT PRIMARY CYTOTOXIC T-CELL RESPONSES IN-VITRO - ENHANCEMENT BY COTRANSFECTION OF GENES ENCODING THE TH1-BIASING CYTOKINES IL-12 AND IFN-ALPHA

      The Journal of immunology
    26. MOSSE CA; MEADOWS L; LUCKEY CJ; KITTLESEN DJ; HUCZKO EL; SLINGLUFF CL; SHABANOWITZ J; HUNT DF; ENGELHARD VH
      THE CLASS-I ANTIGEN-PROCESSING PATHWAY FOR THE MEMBRANE-PROTEIN TYROSINASE INVOLVES TRANSLATION IN THE ENDOPLASMIC-RETICULUM AND PROCESSINGIN THE CYTOSOL

      The Journal of experimental medicine
    27. HOGAN KT; EISINGER DP; CUPP SB; LEKSTROM KJ; DEACON DD; SHABANOWITZ J; HUNT DF; ENGELHARD VH; SLINGLUFF CL; ROSS MM
      THE PEPTIDE RECOGNIZED BY HLA-A68.2-RESTRICTED, SQUAMOUS-CELL CARCINOMA OF THE LUNG-SPECIFIC CYTOTOXIC T-LYMPHOCYTES IS DERIVED FROM A MUTATED ELONGATION-FACTOR-2 GENE

      Cancer research
    28. MOORE MM; NGUYEN D; SLINGLUFF CL; HANKS J; SPOTNITZ WD
      FIBRIN SEALANT REDUCES SEROUS DRAINAGE AND ALLOWS FOR EARLIER DRAIN REMOVAL AFTER AXILLARY DISSECTION FOR EARLY-STAGE BREAST-CARCINOMA - A RANDOMIZED, PROSPECTIVE TRIAL

      Thrombosis and haemostasis
    29. MOORE MM; HARGETT CW; HANKS JB; FAJARDO LL; HARVEY JA; FRIERSON HF; SLINGLUFF CL
      ASSOCIATION OF BREAST-CANCER WITH THE FINDING OF ATYPICAL DUCTAL HYPERPLASIA AT CORE BREAST BIOPSY

      Annals of surgery
    30. SLINGLUFF CL
      TUMOR-ANTIGENS AND TUMOR VACCINES - PEPTIDES AS IMMUNOGENS

      Seminars in surgical oncology
    31. MOSSE CA; KITTLESEN DJ; SKIPPER JCA; HENDRICKSON R; HUNT DF; SLINGLUFF CL; ENGELHARD VH
      A TYROSINASE EPITOPE IS PROCESSED AFTER TRANSLATION INTO THE ENDOPLASMIC-RETICULUM

      The FASEB journal
    32. SKIPPER JCA; KITTLESEN DJ; HENDRICKSON RC; DEACON DD; HARTHUN NL; WAGNER SN; HUNT DF; ENGELHARD VH; SLINGLUFF CL
      SHAVED EPITOPES FOR HLA-A3-RESTRICTED MELANOMA-REACTIVE HUMAN CTL INCLUDE A NATURALLY PROCESSED EPITOPE FROM PMEL-17 GP100/

      The Journal of immunology
    33. SKIPPER JCA; HENDRICKSON RC; GULDEN PH; BRICHARD V; VANPEL A; CHEN Y; SHABANOWITZ J; WOLFEL T; SLINGLUFF CL; BOON T; HUNT DF; ENGELHARD VH
      AN HLA-A2-RESTRICTED TYROSINASE ANTIGEN ON MELANOMA-CELLS RESULTS FROM POSTTRANSLATIONAL MODIFICATION AND SUGGESTS A NOVEL PATHWAY FOR PROCESSING OF MEMBRANE-PROTEINS

      The Journal of experimental medicine
    34. SLINGLUFF CL
      UNTITLED

      Annals of surgery
    35. SLINGLUFF CL; HUNT DF; ENGELHARD VH
      DIRECT ANALYSIS OF TUMOR-ASSOCIATED PEPTIDE ANTIGENS

      Current opinion in immunology
    36. COX AL; SKIPPER J; CHEN Y; HENDERSON RA; DARROW TL; SHABANOWITZ J; ENGELHARD VH; HUNT DF; SLINGLUFF CL
      IDENTIFICATION OF A PEPTIDE RECOGNIZED BY 5 MELANOMA-SPECIFIC HUMAN CYTOTOXIC T-CELL LINES

      Science
    37. SLINGLUFF CL; COX AL; STOVER JM; MOORE MM; HUNT DF; ENGELHARD VH
      CYTOTOXIC T-LYMPHOCYTE RESPONSE TO AUTOLOGOUS HUMAN SQUAMOUS-CELL CANCER OF THE LUNG - EPITOPE RECONSTITUTION WITH PEPTIDES EXTRACTED FROM HLA-AW68

      Cancer research
    38. SLINGLUFF CL; STIDHAM KR; RICCI WM; STANLEY WE; SEIGLER HF
      SURGICAL-MANAGEMENT OF REGIONAL LYMPH-NODES IN PATIENTS WITH MELANOMA- EXPERIENCE WITH 4682 PATIENTS

      Annals of surgery
    39. SLINGLUFF CL; REINTGEN D
      MALIGNANT-MELANOMA AND THE PROGNOSTIC IMPLICATIONS OF PREGNANCY, ORAL-CONTRACEPTIVES, AND EXOGENOUS HORMONES

      Seminars in surgical oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 03:18:57